This recall involves prescription drugs Aprepitant 125 mg capsules sold in cartons containing one blister card of 6 capsules and 5 gram tubes of Lidocaine and Prilocaine cream sold in cartons containing 5 tubes and packed with or without 12 dressings. The Aprepitant capsules are in a non-child resistant blister card packaged in a carton that has the name “Sandoz,” the name of the medication, dosage, NDC number, lot number, and expiration date on the carton and on the blister cards. The warnings “This unit-dose packaging is not child-resistant” and “For institutional use only” are listed on the carton.
The Lidocaine and Prilocaine cream is packaged in a 5 gram tube with a continuous thread white closure. The name “fougera®,” the name of the medication, dosage and NDC number are printed on the carton and tube and the expiration date and lot number are printed on the carton and stamped on the crimp of the tube. The warning “FOR HOSPITAL USE ONLY” is printed on the carton and the tube.
The recall includes the following:
|Product Description||NDC Number||Lot Number||Expiration Date|
|Aprepitant Capsules 125 mg||0781-2323-68 Carton of 1 Blister Pack of 6 capsules
0781-2323-06 Blister Pack
|Lidocaine and Prilocaine 2.5%/2.5% Cream 5 gram Tubes||0168-0357-56 Carton of 5 tubes and 12 dressings
0168-0357-55 Carton of 5 tubes
Consumers should immediately secure the medications out of the sight and reach of children and contact Sandoz for a free child resistant pouch to store the products. Once the medication is secured, consumers can continue to use the medication as directed.
Pharmacies nationwide as a prescribed medicine from October 2020 through January 2023. The prices of the medications varied based on health insurance terms and other factors.
Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream)
Sandoz Inc., of Princeton, New Jersey (Aprepitant Capsules)